1. Pink Sheet

European Industry Proposes Incentive To Develop New Antimicrobials

EFPIA Urges Care Over Definition Of ‘Unmet Medical Need’

 
• By Ian Schofield

With proposals for an overhaul of the EU medicines legislation due at the end of this year, EFPIA has published its formal response to the European Commission’s consultation with suggestions for facilitating new antibiotic development, testing new regulatory approaches to novel medicines, and tackling medicine shortages.

The EU's medicines legislation is under scrutiny • Source: Alamy

The European pharmaceutical industry federation EFPIA has called for the introduction of a “transferable exclusivity extension” as an incentive to encourage companies to invest in the development of new products to tackle antimicrobial resistance (AMR), which it says could easily be implemented via EU legislation.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography